Editorial |

Cannabis, Cognition, and Residual Confounding

Harrison G. Pope, Jr, MD
JAMA. 2002;287(9):1172-1174. doi:10.1001/jama.287.9.1172.
Text Size: A A A
Published online


In this issue of THE JOURNAL, Solowij and colleagues1 report a variety of neuropsychological deficits in long-term cannabis users who were tested a median of 17 hours after their last reported cannabis intake. Their findings of impairments in memory and attention are not surprising since several large and well-controlled studies have found similar deficits on neuropsychological tests administered to long-term cannabis users after 12 to 72 hours of abstinence.25 If these deficits are brief and reversible (ie, due to a residue of cannabinoids lingering in the brain or to withdrawal effects from abruptly stopping the drug), they might not be a serious threat. However, if these deficits are prolonged or irreversible (ie, due to neurotoxicity from years of cumulative cannabis exposure), they become a matter of grave concern. The findings of Solowij and colleagues favor the latter possibility in that longer-term cannabis users in the study often showed significantly greater deficits than shorter-term users, and neuropsychological performance measures were often negatively correlated with lifetime duration of use. Furthermore, these correlations could not be explained by greater withdrawal symptoms or heavier recent cannabis consumption among the longer-term users. Solowij and colleagues1 conclude that "our results confirm that cognitive impairments develop as a result of prolonged cannabis use . . . and [that] they worsen with increasing years of use."

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 36

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles

The Rational Clinical Examination
Assessing Cognition

The Rational Clinical Examination
Relationship Between Cognition and Incapacity